CPSBC’s drug programs continue to evolve under the Health Professions and Occupations Act (HPOA), with a focus on engaging all licensees, including physicians, surgeons, and podiatric surgeons, in safe prescribing practices.
Under the HPOA, the Prescription Review Program (PRP), CPSBC’s formal quality assurance initiative, has approximately 300 files currently under review. The PRP focuses on opioids, sedatives, stimulants, and other medications with potential for diversion or misuse. Work is also underway to develop a quality assurance strategy specific to podiatric surgeons.
Safe prescribing is not only about medications; it is also about behaviours, judgement, and approach. The following CPSBC standards and guidelines are relevant to prescribers.
In addition to the Safe Prescribing of Opioids and Sedatives and Prescribing Methadone practice standards, licensees are reminded of another practice standard which addresses prescribing, Treatment of Self, Family Members and Others Close to You. This standard restricts treating or prescribing for oneself or others where a close personal relationship exists and where objectivity may be compromised.
A new professional guideline, Writing Prescriptions, was published on April 1, 2026. This guideline outlines expectations for required information, proper authorization and transmission, and the management of samples and returned prescriptions.
Prescribing is central to practice and carries both benefit and risk. Licensees are encouraged to commit to continuing education around prescribing, follow current evidence, and maintain patient-centred, well-documented decision-making.